0074-1050Apr 26, 2021 Skyrizi 150 mg/ml Subcutaneous Injection by Abbvie Inc.
0074-1065Sep 23, 2022 SkyriziSkyrizi Kit by Abbvie Inc.
0074-1070Jun 16, 2022 SkyriziSkyrizi Kit by Abbvie Inc.
0074-2042Apr 23, 2019 SkyriziSkyrizi Kit by Abbvie Inc.
0074-2100Apr 26, 2021 Skyrizi 150 mg/ml Subcutaneous Injection by Abbvie Inc.
0074-5015Jun 16, 2022 Skyrizi 60 mg/ml Intravenous Injection by Abbvie Inc.
0074-7034Mar 22, 2023 SkyriziSkyrizi Kit by Abbvie Inc.
0074-7036Mar 22, 2023 SkyriziSkyrizi Kit by Abbvie Inc.
0074-7040Mar 04, 2024 SkyriziSkyrizi Kit by Abbvie Inc.
0074-7042Mar 04, 2024 SkyriziSkyrizi Kit by Abbvie Inc.
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.